In the evolving landscape of diabetes management, novel treatments like semaglutide and retatrutide are gaining traction. These drugs, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist group, offer https://kianaiope828915.blogdiloz.com/37763266/semaglutide-vs-retatrutide-a-novel-comparison-in-diabetes-management